Skip to content
CompanySight
Company No. 02892098 · Incorporated 27 Jan 1994

Infectious Music Limited

Registered name: INFECTIOUS MUSIC LIMITED

Part of BMG Rights Management (UK) Limited group

Infectious Music Limited made £2.5m revenue and £554k profit in the year to 31 Dec 2025.

Infectious Music Limited’s revenue fell 39% to £2.5m in the year to 31 Dec 2025, with £554k profit and 0 employees. The company is classified under “sound recording and music publishing activities” and is based in London; we hold 2 years of its filed accounts.

Full P&L filedSection J · Information and communicationSIC 59200Sound recording and music publishing activities
Status
Active
Location
London, London
Age
32 yrs · since 1994
Type
Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Small team
Revenue
£2.5m
Growth ▼39.3%
Profit
£554k
Growth ▼69.7%
Profit margin
21.9%
Gross 59%
Employees
0
Change —
Profit / employee
—
 
Profitable streak
2yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202431 Dec 2025
DisclosureFull P&LFull P&L
Profit & loss
Revenue (turnover)£4.2m£2.5m
Cost of sales£1.7m£1m
Gross profit£2.4m£1.5m
Operating profit£2m£582k
Profit before tax£2m£638k
Profit after tax£1.8m£554k
Profit (best available)£1.8m£554k
Employees (average)00
Ratios
Profit margin44%21.9%
Gross margin58.3%59%
Growth (year on year)
Revenue growth—▼39.3%
Profit growth—▼69.7%
Balance sheet — indirect signals, not revenue
Net assets£1.5m£2.1m
Current assets£3.1m£3.1m
Debtors£38k£27k
Deferred income£715k£614k
SourceFullAccounts · bulk data Jul 2026FullAccounts · bulk data Jul 2026
Derived from the latest filing

How the business works

Profit margin
21.9%
Profit ÷ revenue.
Gross margin
59%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
—
Revenue ÷ average employees.
Profit per employee
—
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
24.3%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
1.1%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲36%
Now £2.1m
Cash at bank
—
Now —
Headcount
—
Now 0
Deferred income
▼14%
Now £614k
Fixed assets
—
Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. BMG Rights Management (UK) Limitedultimate parent75–100%
  2. Infectious Music Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (25)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £554k), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.